Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
IsraelIPO:
14 July 2021Website:
http://inspira-technologies.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 19:41:12 GMTDividend
Analysts recommendations
Institutional Ownership
IINN Latest News
Inspira (IINN) discloses business goals for 2024-25 with the rapid promotion of INSPIRA ART100 and the development of INSPIRA ART (Gen 2).
Company to aggressively promote INSPIRA™ ART100 in the U.S. and additional markets following FDA clearance, as well as accelerate plans for ground-breaking INSPIRA™ ART (Gen2) RA'ANANA, Israel , June 20, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN), (Nasdaq: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, announced today that the Company's President and co-founder, Mr.
RA'ANANA, Israel , June 17, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, is proud to announce today that the Company will present at the annual iECOs Conference in Herzliya, Israel on June 18th, 2024.
First units expected to be shipped in Q4 2024. The Purchase Order follows the recent FDA Clearance of the INSPIRA™ ART100.
The event is an opportunity to present and demonstrate new products and technologies to potential customers and strategic partners RA'ANANA, Israel , June 5, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, is proud to announce plans to exhibit the INSPIRA™ ART100 System, recently cleared by the U.S. Food and Drug Administration ("FDA"), at the Extracorporeal Life Support Organization (ELSO) conference in Detroit, Michigan between September 29 to October 1, 2024.
RA'ANANA, Israel , May 30, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira") a breakthrough medical technology company, announced today that Company President, Director, and co-founder, Mr.
Inspira Technologies' (IINN) ART100 recent approval highlights the company's innovative advancements in medical technology.
RA'ANANA, Israel , May 28, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company", "Inspira", or "Inspira Technologies"), a breakthrough medical technology company, today announced that it has received notification of 510(k) class II clearance from the U.S. Food and Drug Administration (FDA) for its INSPIRA™ ART100, a Cardiopulmonary Bypass System.
The AMAR submission is a strategic move by Inspira Technologies (IINN), positioning it to target global markets with its innovative Augmented Respiration Technology (INSPIRA ART).
Inspira Technologies' (IINN) proprietary orbiting oxygenation technology eliminates the need for membrane fibers, thereby reducing pressure differentials and high shear stress.
What type of business is Inspira Technologies Oxy BHN?
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
What sector is Inspira Technologies Oxy BHN in?
Inspira Technologies Oxy BHN is in the Healthcare sector
What industry is Inspira Technologies Oxy BHN in?
Inspira Technologies Oxy BHN is in the Medical Devices industry
What country is Inspira Technologies Oxy BHN from?
Inspira Technologies Oxy BHN is headquartered in Israel
When did Inspira Technologies Oxy BHN go public?
Inspira Technologies Oxy BHN initial public offering (IPO) was on 14 July 2021
What is Inspira Technologies Oxy BHN website?
https://inspira-technologies.com
Is Inspira Technologies Oxy BHN in the S&P 500?
No, Inspira Technologies Oxy BHN is not included in the S&P 500 index
Is Inspira Technologies Oxy BHN in the NASDAQ 100?
No, Inspira Technologies Oxy BHN is not included in the NASDAQ 100 index
Is Inspira Technologies Oxy BHN in the Dow Jones?
No, Inspira Technologies Oxy BHN is not included in the Dow Jones index
When does Inspira Technologies Oxy BHN report earnings?
Next earnings report date is not announced yet